https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212937
TC BioPharm Announces Successful Completion Of Safety Cohort And Gives Data Safety Monitoring Board Results; No Significant Safety Concerns Observed In Safety Cohort
No Significant Safety Concerns Observed in Safety CohortManagement expects to expand ACHIEVE trial in Q1EDINBURGH, Scotland, Nov. 14, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company")